Core Laboratories Statistics
Total Valuation
CLB has a market cap or net worth of $696.12 million. The enterprise value is $837.60 million.
| Market Cap | 696.12M |
| Enterprise Value | 837.60M |
Important Dates
The last earnings date was Wednesday, October 22, 2025, after market close.
| Earnings Date | Oct 22, 2025 |
| Ex-Dividend Date | Nov 3, 2025 |
Share Statistics
CLB has 46.56 million shares outstanding. The number of shares has decreased by -0.39% in one year.
| Current Share Class | 46.56M |
| Shares Outstanding | 46.56M |
| Shares Change (YoY) | -0.39% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 111.51% |
| Float | 46.05M |
Valuation Ratios
The trailing PE ratio is 21.99 and the forward PE ratio is 20.20. CLB's PEG ratio is 13.84.
| PE Ratio | 21.99 |
| Forward PE | 20.20 |
| PS Ratio | 1.35 |
| Forward PS | n/a |
| PB Ratio | 2.54 |
| P/TBV Ratio | 4.21 |
| P/FCF Ratio | 20.25 |
| P/OCF Ratio | 14.01 |
| PEG Ratio | 13.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.50, with an EV/FCF ratio of 24.36.
| EV / Earnings | 26.07 |
| EV / Sales | 1.62 |
| EV / EBITDA | 13.50 |
| EV / EBIT | 17.67 |
| EV / FCF | 24.36 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.60.
| Current Ratio | 2.37 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | 4.86 |
| Interest Coverage | 4.48 |
Financial Efficiency
Return on equity (ROE) is 12.26% and return on invested capital (ROIC) is 6.61%.
| Return on Equity (ROE) | 12.26% |
| Return on Assets (ROA) | 4.97% |
| Return on Invested Capital (ROIC) | 6.61% |
| Return on Capital Employed (ROCE) | 9.57% |
| Revenue Per Employee | $147,858 |
| Profits Per Employee | $9,178 |
| Employee Count | 3,500 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 6.70 |
Taxes
In the past 12 months, CLB has paid $11.49 million in taxes.
| Income Tax | 11.49M |
| Effective Tax Rate | 25.98% |
Stock Price Statistics
The stock price has decreased by -28.26% in the last 52 weeks. The beta is 1.08, so CLB's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -28.26% |
| 50-Day Moving Average | 13.78 |
| 200-Day Moving Average | 12.86 |
| Relative Strength Index (RSI) | 52.10 |
| Average Volume (20 Days) | 515,795 |
Short Selling Information
The latest short interest is 5.52 million, so 11.85% of the outstanding shares have been sold short.
| Short Interest | 5.52M |
| Short Previous Month | 6.88M |
| Short % of Shares Out | 11.85% |
| Short % of Float | 11.98% |
| Short Ratio (days to cover) | 8.21 |
Income Statement
In the last 12 months, CLB had revenue of $517.50 million and earned $32.12 million in profits. Earnings per share was $0.68.
| Revenue | 517.50M |
| Gross Profit | 103.23M |
| Operating Income | 47.41M |
| Pretax Income | 44.22M |
| Net Income | 32.12M |
| EBITDA | 62.06M |
| EBIT | 47.41M |
| Earnings Per Share (EPS) | $0.68 |
Balance Sheet
The company has $25.63 million in cash and $167.10 million in debt, giving a net cash position of -$141.47 million or -$3.04 per share.
| Cash & Cash Equivalents | 25.63M |
| Total Debt | 167.10M |
| Net Cash | -141.47M |
| Net Cash Per Share | -$3.04 |
| Equity (Book Value) | 277.39M |
| Book Value Per Share | 5.89 |
| Working Capital | 131.17M |
Cash Flow
In the last 12 months, operating cash flow was $49.70 million and capital expenditures -$15.32 million, giving a free cash flow of $34.38 million.
| Operating Cash Flow | 49.70M |
| Capital Expenditures | -15.32M |
| Free Cash Flow | 34.38M |
| FCF Per Share | $0.74 |
Margins
Gross margin is 19.95%, with operating and profit margins of 9.16% and 6.21%.
| Gross Margin | 19.95% |
| Operating Margin | 9.16% |
| Pretax Margin | 8.54% |
| Profit Margin | 6.21% |
| EBITDA Margin | 11.99% |
| EBIT Margin | 9.16% |
| FCF Margin | 6.64% |
Dividends & Yields
This stock pays an annual dividend of $0.04, which amounts to a dividend yield of 0.27%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.88% |
| Buyback Yield | 0.39% |
| Shareholder Yield | 0.66% |
| Earnings Yield | 4.61% |
| FCF Yield | 4.94% |
Analyst Forecast
The average price target for CLB is $12.50, which is -16.39% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.50 |
| Price Target Difference | -16.39% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CLB has an Altman Z-Score of 3.15 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.15 |
| Piotroski F-Score | 5 |